Search alternatives:
significantly shorter » significantly higher (Expand Search), significantly lower (Expand Search), significantly greater (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
shorter decrease » reported decrease (Expand Search), scores decreased (Expand Search), larger decrease (Expand Search)
Showing 581 - 600 results of 21,342 for search '(( significantly shorter decrease ) OR ( significant decrease decrease ))', query time: 0.43s Refine Results
  1. 581
    One-way ANCOVA results for Task 2. The bold values highlight statistically significant results of Task 2.

    One-way ANCOVA results for Task 2. The bold values highlight statistically significant results of Task 2. by Mucahit Gemici (21519313)

    Published 2025
    Save to List
    Saved in:
  2. 582
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 583
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 584
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 585
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 586
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 587
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 588
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 589
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 590
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 591
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 592
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 593
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 594
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 595
    Estimated average absolute and relative changes in energy (kcal/capita/day) from the no-policy counterfactual by phase, high-in status, and SES.

    Estimated average absolute and relative changes in energy (kcal/capita/day) from the no-policy counterfactual by phase, high-in status, and SES. by Lindsey Smith Taillie (3159258)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 596
    Estimated average absolute and relative changes in energy (kcal/capita/day) from the no-policy counterfactual by phase and number of excess nutrients of concern.

    Estimated average absolute and relative changes in energy (kcal/capita/day) from the no-policy counterfactual by phase and number of excess nutrients of concern. by Lindsey Smith Taillie (3159258)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 597
    Weighted sociodemographic characteristics of the Kantar WorldPanel sample by year.

    Weighted sociodemographic characteristics of the Kantar WorldPanel sample by year. by Lindsey Smith Taillie (3159258)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 598
    Estimated average absolute and relative changes from the no-policy counterfactual by phase and high-in status.

    Estimated average absolute and relative changes from the no-policy counterfactual by phase and high-in status. by Lindsey Smith Taillie (3159258)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 599
    Mean observed, fitted, and counterfactual energy, saturated fat, sodium, and sugar per capita per day from high-in food and beverage purchases.

    Mean observed, fitted, and counterfactual energy, saturated fat, sodium, and sugar per capita per day from high-in food and beverage purchases. by Lindsey Smith Taillie (3159258)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 600
    Estimated average absolute and relative changes from the no-policy counterfactual by phase and beverage group.

    Estimated average absolute and relative changes from the no-policy counterfactual by phase and beverage group. by Lindsey Smith Taillie (3159258)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: